A Monoclonal Antibody to a Carbohydrate Epitope Expressed on Glycolipid and on α3β1 Integrin on Human Esophageal Carcinoma

Hybridoma and Hybridomics

Volumn 22, Issue 6, 2003, Pages 367-376

  Jamasbi, Roudabeh J ^a   Stoner, Gary D ^b   Foote, Linda J ^c   Lankford, Trish K ^c   Davern, Sandra ^c   Kennel, Stephen J ^c  

^a BOWLING GREEN STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OAK RIDGE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; DETERGENT; EPITOPE; GLUCAN SYNTHASE; GLYCOLIPID; IODINE 125; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 9; PERIODIC ACID; SIALIDASE; TRYPSIN; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 3;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS CARCINOMA; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; IMMUNIZATION; ISOTOPE LABELING; MASS SPECTROMETRY; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALIA; ILEX COOKII;

EID: 0346394006     PISSN: 15368599     EISSN: None     Source Type: Journal    
DOI: 10.1089/153685903771797066     Document Type: Article

References (36)

1. Nadkarni JS, Bhadsavle PR, Chitnis VS, Nadkarni JJ, Vyas JS, and Desai PB: Characterization of a murine monoclonal antibody against human esophageal squamous cell carcinoma-associated antigen. Tumori 1998;84:578-582.
2. Hsieh HG, Hu CP, Han SH, Chen LR, Chien KY, Chou CK, Ting LP, Su TS, Huang MH, Hsu WH, et al. Monoclonal antibodies against human esophageal carcinoma cell lines. Zhonghua Min Guo Wei Sheng, Wu JI, Mian Yi Xue Za Zhi 1987;20:179-189.
3. Naito M, Imamura M, Kannagi R, and Tobe T: Production of monoclonal antibody to human esophageal cancer cell line. Jpn J Surg 1990;20:170-179.
4. Tomita Y: A monoclonal antibody reactive with human squamous cell carcinoma of the esophagus. Nippon Geka Gakkai Zasshi 1994;95:425-434.
5. Fujii T, Yamana H, Toh Y, Toh U, Fujita H, Shirouzu K, and Morimatsu M: The effect of radioimmunotherapy using murine monoclonal antibody KIS1 on esophageal squamous cell carcinoma-bearing nude mice. Surg Today 1997;27:1026-1034.
6. Sagara M, Yonezawa S, Nagata K, Tezuka Y, Natsugoe S, Xing PX, McKenzie IF, Aikou T, and Sato E: Expression of mucin 1 (MUC1) in esophageal squamous-cell carcinoma: its relationship with prognosis. Int J Cancer 1999;84:251-257.
7. Ikeda Y, Kuwano H, Baba K, Ikebe M, Matushima T, Adachi Y, Mori M, and Sugimachi K: Expression of Sialyl-Tn antigens in normal squamous epithelium, dysplasia, and squamous cell carcinoma in the esophagus. Cancer Res 1993;53:1706-1708.
8. Sato M, Narita T, Kawakami-Kimura N, Higashiyama S, Taniguchi N, Akiyama S, Hashimoto T, Manabe T, and Kannagi R: Increased expression of integrins by heparin-binding EGF like growth factor in human esophageal cancer cells. Cancer Lett 1996;102:183-191.
9. Nishihira T, Kasai M, Mori S, Watanabe T, Kuriya Y, Suda M, Kitamura M, Hirayama K, Akaishi T, and Sasaki T: Characteristics of two cell lines (TE-1 and TE-2) derived from human squamous cell carcinomas of the esophagus. Gann 1979;70:575-584.
10. Hakomori S: Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res 1996;56:5309-5318.
11. Dablsteen, E: Cell surface carbohydrates as prognostic markers in human carcinomas. J Pathol 1996;179:358-369.
12. Sotiropoulou G, Kono M, Anisowicz A, Stenman G, Tsuji S, and Sager R: Identification and functional characterization of a human GalNAc [alpha] 2,6-sialyltransferase with altered expression in breast cancer. Mol Med 2002;8:42-55.
13. Fox DA, He X, Abe A, Hollander T, Li LL, Kan L, Friedman AW, Shimizu Y, Shayman JA, and Kozarsky K: The T lymphocyte structure CD60 contains a sialylated carbohydrate epitope that is expressed on both gangliosides and glycoproteins. Immunol Invest 2001;30:67-85.
14. Satyamoorthy K, and Herlyn M: Cellular and molecular biology of human melanoma. Cancer Biol Ther 2002;1:14-17.
15. Basak S, Birebent B, Purev E, Somasundaram R, Maruyama H, Zaloudik J, Swoboda R, Strittmatter W, Li W, Luckenbach A, Song H, Li J, Sproesser K, Guerry D, Nair S, Furukawa K, and Herlyn D: Induction of cellular immunity by anti-idiotypic antibodies mimicking GD2 ganglioside. Cancer Immunol Immunother 2003;52:145-154.
16. Chen HH, Fukumoto S, Furukawa K, Nakao A, Akiyama S, Urano T, and Furukawa K: Suppression of lung metastasis of mouse Lewis lung cancer p29 with transfection of the ganglioside GM2/GD2 synthase gene. Int J Cancer 2003;103:169-176.
17. Burdick MM, McCaffery JM, Kim YS, Bochner BS, and Konstantopoulos K: Colon carcinoma cell glycolipids, integrins, and other glycoproteins mediate adhesion to HUVECs under flow. Am J Physiol Cell Physiol 2003;284:77-87.
18. Higai K, Shibukawa K, Muto S, and Matsumoto K: Targeted proteo-glycomics analysis of Sialyl Lewis X antigen expressing glycoproteins secreted by human hepatoma cell line. Anal Sci 2003;19:85-92.
19. Shimada Y, Imamura M, Wagata T, Yamaguchi N, and Tobe T: Characterization of 21 newly established esophageal cancer cell lines. Cancer 1992;69:277-284.
20. Hu CP, Hsieh HG, Chien KY, Wang PY, Wang CI, Chen CY, Lo SJ, Wuu KD, and Chang CM: Biologic properties of three newly established human esophageal carcinoma cell lines. J Natl Cancer Inst 1984;72:577-583.
21. Bey E, Alexander J, Whitcutt JM, Hunt JA, and Gear JH: Carcinoma of the esophagus in Africans: establishment of a continuously growing line from a tumor specimen. In Vitro 1976;12:107-114.
22. Jamasbi RJ, Kennel SJ, and Stoner GD: A monoclonal antibody produced against a rat esophageal carcinoma cell line reacts with an integrin-like molecule expressed by rat epithelial cells. Hybridoma 1992;11:581-594.
23. Kennel SJ, Lankford TK, Foote LJ, Shinpock SG, and Stringer C: CD44 expression on murine tissues. J Cell Sci 1993;104:373-382.
24. Smith PK. Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, and Klenk DC: Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76-85.
25. Wan X, Jamasbi RJ, and Stoner GD: Characterization of a monoclonal antibody reactive with a glycolipid expressed by tumorigenic and certain immortalized, non-tumorigenic rat esophageal epithelial cell lines. Cancer Immunol Immunother 1993;36:94-100.
26. Kennel SJ, Lankford PK, Foote LJ, and Davis IA: Monoclonal antibody to rat CD63 detects different molecular forms in rat tissue. Hybridoma 1998;17:509-515.
27. Mandler R, Wu C, Sausville EA, Roettinger AJ, Newman DJ, Ho DK, King CR, Yang D, Lippman ME, Landolfi NF, Dadachova E, Brechbiel MW, Waldmann TA: Immunoconjugates of gel-danamycin and anti-HER2 monoclonal antibodies: antiproliferative activity on human breast carcinoma cell lines. J Natl Cancer Inst 2000;92:1573-1581.
28. Yogeeswaran G: Cell surface glycolipids and glycoproteins in malignant transformation. Adv Cancer Res 1983;38:289-350.
29. 1 integrin clustering and stimulates cell migration. Cancer Res 2002;62:6837-6845.
30. Dennis JW, Laferte S, Waghorne C, Breitman ML, and Kerbel RS: Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 1987;236:582-585.
31. Miyake M, and Hakomori SI: A specific cell surface glycoconjugate controlling cell motility: evidence by functional monoclonal antibodies that inhibit cell motility and tumor cell metastasis. Biochemistry 1991;30:3328-3334.
32. Ravindranath MH, Morton DL, and Irie RF: An epitope common to ganglioside O-acetyl-GD3 and GD3 recognized by antibodies in melanoma patients after active specific immunotherapy. Cancer Res. 1989;49:3891-3897.
33. 1 integrin glycans from different human bladder cell lines. Aeta Biochem Polonica 2000;47:427-434.
34. 1 expressed by human colon cancer cells is a major carrier of oncodevelopmental carbohydrate epitopes. J Cell Biochem 1999;72:189-209.
35. Dabelsteen E: ABO blood group antigen in oral mucosa. What is new? J Oral Pathol Med 2002;31:65-69.
36. Ichikawa D, Handa K, and Hakomori S: Histo-blood group A/B antigen deletion/reduction vs. continuous expression in human tumor cells as correlated with their malignancy. Int J Cancer 1998;76:284-289.